Scilex Holding Company has signed a securities purchase agreement with an institutional investor to exchange $200 million worth of Semnur Pharmaceuticals, Inc. common stock for the equivalent of bitcoin. Under the terms of the agreement, Scilex Holding Company's common stock in Semnur Pharmaceuticals will be exchanged with institutional investors at a valuation of $200 million in exchange for the equivalent in Bitcoin.